ArticleIDCases2024
Multimodal imaging findings of multiple evanescent white dot syndrome in COVID-19 patients.
Article in IDCases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To describe the multimodal imaging findings of a rare case of multiple evanescent white dot syndrome (MEWDS) associated with COVID-19. Methods: A case report was analyzed and described alongside COVID-19 associated MEWDS cases identified in the current literature. Results: A healthy 20-year-old man was evaluated after a three-day history of blurry vision occurring two months after COVID-19 infection. Multimodal imaging revealed signs of typical MEWDS, with optical coherence tomography angiography (OCT-A) demonstrating homogenous reflectivity. Six additional cases were reported in the literature, displaying clinical symptoms and imaging consistent with typical MEWDS but demonstrating higher rates of incomplete visual recovery and treatment use. Conclusions: COVID-19 associated MEWDS is a novel condition. This is the first known case of COVID-19 associated MEWDS with reported OCT-A findings in an otherwise healthy patient. Although posterior uveitis following COVID-19 infection is rare, clinicians should remain informed on the best practices for diagnosing and caring for patients with MEWDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.